Files
2026-07-06 17:28:36 -04:00

7.6 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Health insurance; cost-sharing payments for prescription insulin drugs. Health insurance; cost-sharing payments for prescription insulin drugs. Prohibits health insurance companies and other carriers from setting an amount exceeding $30 per 30-day supply that a covered person is required to pay at the point of sale in order to receive a covered prescription insulin drug. The measure also prohibits a provider contract between a carrier or its pharmacy benefits manager and a pharmacy from containing a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription insulin drug in an amount that exceeds such limitation. This bill incorporates HB 1403. us/states/va Virginia General Assembly 2020 HB 66 Virginia HB 66 (2020)
bill
enacted
Lee J. Carter
4 34 7 2019-12-05 2020-04-08 openstates ocd-bill/613b6582-3319-48ec-bb57-6a7ef6635829 https://lis.virginia.gov/cgi-bin/legp604.exe?201+sum+HB66 a2edcc375b650b838725c1c6acf1741a213a1cbe49fd383dd77e916e088848c8 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-va

Virginia HB 66 (2020) — Health insurance; cost-sharing payments for prescription insulin drugs.

Health insurance; cost-sharing payments for prescription insulin drugs. Prohibits health insurance companies and other carriers from setting an amount exceeding $30 per 30-day supply that a covered person is required to pay at the point of sale in order to receive a covered prescription insulin drug. The measure also prohibits a provider contract between a carrier or its pharmacy benefits manager and a pharmacy from containing a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription insulin drug in an amount that exceeds such limitation. This bill incorporates HB 1403.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. Acts of Assembly Chapter text (CHAP0881) (committee substitute) — source
  2. Bill text as passed House and Senate (HB66ER) (committee substitute) — source
  3. Engrossed by House - committee substitute HB66H1 (committee substitute) — source
  4. Impact statement from SCC (HB66) (committee substitute) — source

Votes

  • Reported from Commerce and Labor with amendment (9-Y 6-N) — 96 (pass) · upper
  • VOTE: Passage (98-Y 1-N) — 971 (pass) · lower
  • Subcommittee recommends reporting (4-Y 2-N) — 42 (pass) · lower
  • Passed Senate with amendment (24-Y 16-N) — 2416 (pass) · upper
  • Constitutional reading dispensed (40-Y 0-N) — 400 (pass) · upper
  • Reported from Labor and Commerce with substitute (17-Y 1-N) — 171 (pass) · lower
  • VOTE: Adoption (88-Y 4-N) — 874 (pass) · lower

Sponsors

  • Lee J. Carter — primary (person)
  • Alex Q. Askew — cosponsor (person)
  • Alfonso H. Lopez — cosponsor (person)
  • Charniele L. Herring — cosponsor (person)
  • Chris L. Hurst — cosponsor (person)
  • Clinton L. Jenkins — cosponsor (person)
  • Dan I. Helmer — cosponsor (person)
  • Danica A. Roem — cosponsor (person)
  • Dawn M. Adams — cosponsor (person)
  • Delores L. McQuinn — cosponsor (person)
  • Don L. Scott — cosponsor (person)
  • Glenn R. Davis — cosponsor (person)
  • Hala S. Ayala — cosponsor (person)
  • Ibraheem S. Samirah — cosponsor (person)
  • James A. "Jay" Leftwich — cosponsor (person)
  • Jeffrey M. Bourne — cosponsor (person)
  • Jeion A. Ward — cosponsor (person)
  • Jerrauld C. "Jay" Jones — cosponsor (person)
  • Joseph D. Morrissey — cosponsor (person)
  • Joshua G. Cole — cosponsor (person)
  • Kathleen Murphy — cosponsor (person)
  • Kathy K.L. Tran — cosponsor (person)
  • Kenneth R. Plum — cosponsor (person)
  • Lashrecse D. Aird — cosponsor (person)
  • Marcia S. "Cia" Price — cosponsor (person)
  • Marcus B. Simon — cosponsor (person)
  • Mark H. Levine — cosponsor (person)
  • Mark L. Keam — cosponsor (person)
  • Martha M. Mugler — cosponsor (person)
  • Nancy D. Guy — cosponsor (person)
  • Patrick A. Hope — cosponsor (person)
  • Paul E. Krizek — cosponsor (person)
  • Rodney T. Willett — cosponsor (person)
  • Roslyn C. Tyler — cosponsor (person)
  • Sally L. Hudson — cosponsor (person)
  • Sam Rasoul — cosponsor (person)
  • Shelly A. Simonds — cosponsor (person)
  • Steve E. Heretick — cosponsor (person)
  • Suhas Subramanyam — cosponsor (person)
  • Vivian E. Watts — cosponsor (person)
  • Wendy W. Gooditis — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2019-12-05 Prefiled and ordered printed; offered 01/08/20 20100840D introduction
  • 2019-12-05 Referred to Committee on Labor and Commerce referral-committee
  • 2020-01-14 Assigned L & C sub: Subcommittee #2 referral-committee
  • 2020-01-16 Impact statement from SCC (HB66)
  • 2020-01-16 Subcommittee recommends reporting (4-Y 2-N)
  • 2020-01-28 Committee substitute printed 20107156D-H1 substitution
  • 2020-01-28 Incorporates HB1403 (Leftwich)
  • 2020-01-28 Reported from Labor and Commerce with substitute (17-Y 1-N) committee-passage
  • 2020-01-30 Read first time reading-1
  • 2020-01-31 Read second time reading-2
  • 2020-01-31 Passed by temporarily
  • 2020-01-31 Committee substitute agreed to 20107156D-H1
  • 2020-01-31 Engrossed by House - committee substitute HB66H1
  • 2020-02-03 Read third time and passed House (98-Y 1-N) passage, reading-3
  • 2020-02-03 VOTE: Passage (98-Y 1-N)
  • 2020-02-04 Constitutional reading dispensed
  • 2020-02-04 Referred to Committee on Commerce and Labor referral-committee
  • 2020-02-04 Impact statement from SCC (HB66H1)
  • 2020-03-02 Reported from Commerce and Labor with amendment (9-Y 6-N) committee-passage
  • 2020-03-04 Constitutional reading dispensed (40-Y 0-N)
  • 2020-03-05 Read third time reading-3
  • 2020-03-05 Reading of amendment waived
  • 2020-03-05 Committee amendment agreed to
  • 2020-03-05 Engrossed by Senate as amended
  • 2020-03-05 Passed Senate with amendment (24-Y 16-N) passage
  • 2020-03-05 Senate amendment agreed to by House (88-Y 4-N)
  • 2020-03-05 VOTE: Adoption (88-Y 4-N)
  • 2020-03-12 Enrolled
  • 2020-03-12 Signed by Speaker
  • 2020-03-12 Signed by President
  • 2020-03-13 Impact statement from SCC (HB66ER)
  • 2020-03-17 Enrolled Bill communicated to Governor on March 17, 2020
  • 2020-03-17 Governor's Action Deadline 11:59 p.m., April 11, 2020
  • 2020-04-08 Approved by Governor-Chapter 881 (effective 7/1/20) executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/613b6582-3319-48ec-bb57-6a7ef6635829. Confidence: reported (aggregated from official Virginia legislature records).